139 related articles for article (PubMed ID: 7453889)
1. [Remarks on clozapine].
Steinbauer G; Diehl LW
Nervenarzt; 1980 Jun; 51(6):373-4. PubMed ID: 7453889
[No Abstract] [Full Text] [Related]
2. [Clozapine (Leponex)].
Bilikiewicz A; Sulestrowska H
Psychiatr Pol; 1977; 11(2):251-3. PubMed ID: 887685
[No Abstract] [Full Text] [Related]
3. Clozapine-induced agranulocytosis: non-cross-reactivity with other psychotropic drugs.
Lieberman JA; Johns CA; Kane JM; Rai K; Pisciotta AV; Saltz BL; Howard A
J Clin Psychiatry; 1988 Jul; 49(7):271-7. PubMed ID: 3391979
[TBL] [Abstract][Full Text] [Related]
4. [Clozapine and agranulocytosis].
Xu SH
Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1984 Oct; 17(5):271-2. PubMed ID: 6537285
[No Abstract] [Full Text] [Related]
5. [Clozepine (Leponex)].
Gerlach J
Ugeskr Laeger; 1984 Dec; 146(50):3943-4. PubMed ID: 6523596
[No Abstract] [Full Text] [Related]
6. [Hematological complications caused by clozapine (Leponex)].
Palva I
Duodecim; 1976; 92(1):1-2. PubMed ID: 1248428
[No Abstract] [Full Text] [Related]
7. Clozapine withdrawal rebound psychosis.
Borison RL; Diamond BI; Sinha D; Gupta RP; Ajiboye PA
Psychopharmacol Bull; 1988; 24(2):260-3. PubMed ID: 3212159
[No Abstract] [Full Text] [Related]
8. [Studies on side-effects in treatment of psychoses with clozapine (Leponex)].
Kirkegaard A; Jensen A
Ugeskr Laeger; 1977 Nov; 139(47):2800-5. PubMed ID: 595167
[No Abstract] [Full Text] [Related]
9. Clozapine--a potential antipsychotic agent without extrapyramidal manifestations.
Matz R; Rick W; Oh D; Thompson H; Gershon S
Psychopharmacol Bull; 1975 Jan; 11(1):14. PubMed ID: 1121559
[No Abstract] [Full Text] [Related]
10. Clozapine-induced agranulocytosis.
Anger B; Reichert S; Heimpel H
Blut; 1987 Jan; 54(1):63-4. PubMed ID: 3801680
[No Abstract] [Full Text] [Related]
11. FDA's position on the clozaril patient management system.
Peck CC
Hosp Community Psychiatry; 1990 Aug; 41(8):876-7. PubMed ID: 2401475
[No Abstract] [Full Text] [Related]
12. Clozapine and agranulocytosis.
Senn HJ; Jungi WF; Kunz H; Pöldinger W
Lancet; 1977 Mar; 1(8010):547. PubMed ID: 65644
[No Abstract] [Full Text] [Related]
13. Letter: Clozapine and agranulocytosis.
Griffith RW; Saameli K
Lancet; 1975 Oct; 2(7936):657. PubMed ID: 52022
[No Abstract] [Full Text] [Related]
14. Letter: Clozapine and agranulocytosis.
Idänpään-Heikkilä J; Alhava E; Olkinuora M; Palva I
Lancet; 1975 Sep; 2(7935):611. PubMed ID: 51442
[No Abstract] [Full Text] [Related]
15. [Patient knowledge regarding Clozapine-induced agranulocytosis].
Haberfellner EM; Rittmannsberger H
Psychiatr Prax; 2006 May; 33(4):194-6. PubMed ID: 16680627
[No Abstract] [Full Text] [Related]
16. Clozapine-induced agranulocytosis: a situation report up to August 1976.
Anderman B; Griffith RW
Eur J Clin Pharmacol; 1977 Mar; 11(3):199-201. PubMed ID: 852497
[TBL] [Abstract][Full Text] [Related]
17. [Acute bone marrow and liver damage during treatment with clozapine].
Brodowski L; Matusewicz W; Urbańska-Ryś H; Krykowski E
Pol Tyg Lek; 1984 May; 39(21):721-2. PubMed ID: 6483677
[No Abstract] [Full Text] [Related]
18. Drug-induced agranulocytosis: review of possible mechanisms, and prospects for clozapine studies.
Claas FH
Psychopharmacology (Berl); 1989; 99 Suppl():S113-7. PubMed ID: 2682726
[TBL] [Abstract][Full Text] [Related]
19. [The most common complications in neuroleptic therapy. A case report].
Preradović M
Vojnosanit Pregl; 1981; 38(3):211-2. PubMed ID: 7281540
[No Abstract] [Full Text] [Related]
20. Agranulocytosis during treatment with chlozapine.
Idänpään-Heikkilä J; Alhava E; Olkinuora M; Palva IP
Eur J Clin Pharmacol; 1977 Mar; 11(3):193-8. PubMed ID: 856603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
